Cullinan Therapeutics (CGEM) Net Margin (2021)
Historic Net Margin for Cullinan Therapeutics (CGEM) over the last 1 years, with Q1 2021 value amounting to 7.49%.
- Cullinan Therapeutics' Net Margin changed N/A to 7.49% in Q1 2021 from the same period last year, while for Dec 2021 it was 356.25%, marking a year-over-year change of. This contributed to the annual value of 356.25% for FY2021, which is N/A changed from last year.
- Per Cullinan Therapeutics' latest filing, its Net Margin stood at 7.49% for Q1 2021.
- Over the past 5 years, Cullinan Therapeutics' Net Margin peaked at 7.49% during Q1 2021, and registered a low of 7.49% during Q1 2021.